N, performed the experiments; Jie Feng, Megan Weitner, David Sullivan, and Ying Zhang analyzed the information; and Megan Weitner, Jie Feng, Ying Zhang wrote the paper. Conflicts of Interest The authors declare no conflict of interest. References 1. 2. Centers for Illness Control and Prevention. Lyme Disease. Available on the net: cdc.gov/lyme/ (accessed on 5 June 2015). Hinckley, A.F.; Connally, N.P.; Meek, J.I.; Johnson, B.J.; Kemperman, M.M.; Feldman, K.A.; White, J.L.; Mead, P.S. Lyme illness testing by substantial commercial laboratories within the Usa. Clin. Infect. Dis. 2014, 59, 676sirtuininhibitor81. Radolf, J.D.; Caimano, M.J.; Stevenson, B.; Hu, L.T. Of ticks, mice and males: Understanding the dual-host life style of lyme disease spirochaetes. Nat. Rev. Microbiol. 2012, ten, 87sirtuininhibitor9. Wormser, G.P.; Dattwyler, R.J.; Shapiro, E.D.; Halperin, J.J.; Steere, A.C.; Klempner, M.S.; Krause, P.J.; Bakken, J.S.; Strle, F.; Stanek, G.; et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice recommendations by the infectious ailments society of america.IGF2R Protein Formulation Clin.gp140 Protein Species Infect. Dis. 2006, 43, 1089sirtuininhibitor134. Centers for Illness Handle and Prevention. Post Remedy Lyme Disease. Accessible online: cdc.PMID:32926338 gov/lyme/postLDS (accessed on 5 June 2015). Adrion, E.R.; Aucott, J.; Lemke, K.W.; Weiner, J.P. Overall health care costs, utilization and patterns of care following lyme disease. PLoS A single 2015, 10, e0116767. Aucott, J.N.; Rebman, A.W.; Crowder, L.A.; Kortte, K.B. Post-treatment lyme illness syndrome symptomatology plus the effect on life functioning: Is there a thing theresirtuininhibitor Qual. Life Res. 2013, 22, 75sirtuininhibitor4. Phillips, S.E.; Mattman, L.H.; Hulinska, D.; Moayad, H. A proposal for the reputable culture of Borrelia burgdorferi from individuals with chronic lyme disease, even from these previously aggressively treated. Infection 1998, 26, 364sirtuininhibitor67.three. four.5. six. 7.eight.Antibiotics 2015, four 9. 10.11. 12. 13.14. 15. 16. 17. 18.19.20.21.22. 23.24.25.Barthold, S.W.; Hodzic, E.; Imai, D.M.; Feng, S.; Yang, X.; Luft, B.J. Ineffectiveness of tigecycline against persistent Borrelia burgdorferi. Antimicrob. Agents Chemother. 2010, 54, 643sirtuininhibitor51. Embers, M.E.; Barthold, S.W.; Borda, J.T.; Bowers, L.; Doyle, L.; Hodzic, E.; Jacobs, M.B.; Hasenkampf, N.R.; Martin, D.S.; Narasimhan, S.; et al. Persistence of Borrelia burgdorferi in Rhesus macaques following antibiotic therapy of disseminated infection. PLoS One 2012, 7, e29914. Hodzic, E.; Imai, D.; Feng, S.; Barthold, S.W. Resurgence of persisting non-cultivable Borrelia burgdorferi following antibiotic remedy in mice. PLoS One 2014, 9, e86907. Straubinger, R.K.; Summers, B.A.; Chang, Y.F.; Appel, M.J. Persistence of Borrelia burgdorferi in experimentally infected dogs right after antibiotic remedy. J. Clin. Microbiol. 1997, 35, 111sirtuininhibitor16. Marques, A.; Telford, S.R., 3rd; Turk, S.P.; Chung, E.; Williams, C.; Dardick, K.; Krause, P.J.; Brandeburg, C.; Crowder, C.D.; Carolan, H.E.; et al. Xenodiagnosis to detect Borrelia burgdorferi infection: A first-in-human study. Clin. Infect. Dis. 2014, 58, 937sirtuininhibitor45. Hodzic, E.; Feng, S.; Holden, K.; Freet, K.J.; Barthold, S.W. Persistence of Borrelia burgdorferi following antibiotic therapy in mice. Antimicrob. Agents Chemother. 2008, 52, 1728sirtuininhibitor736. Bayer, M.E.; Zhang, L.; Bayer, M.H. Borrelia burgdorferi DNA in the uri.
